Net sales declined 10.7% year-over-year, but operating and ordinary profits increased, with EPS rising to ¥121.57. Full-year guidance forecasts lower sales and profit, while the equity ratio and R&D spending improved.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.